NDC codes

370405 NDC codes with hospital pricing data in the network.

• NDC 65250013304A — BUPIVACAINE LIPO 133 MG/10ML (5 hospitals, 40–400 samples)
• NDC 09991-1522-00 — Enoxaparin 20 mg/mL subcutaneous syringeAI (20 hospitals, 40–400 samples)
• NDC 63323084202A — DICYCLOMINE 10MG/ML INJECTION (13 hospitals, 40–400 samples)
• NDC 338080304 — Dextrose, saline and potassium IV fluid bagAI (177 hospitals, 111–399 samples)
• NDC 143985925 — Ceftriaxone 250 mg injectionAI (39 hospitals, 255–399 samples)
• NDC 641614225 — Phenylephrine 10 mg/mL injectionAI (114 hospitals, 165–399 samples)
• NDC 00781-9242-95 — Ampicillin sodium 250 mg injection powderAI (101 hospitals, 66–399 samples)
• NDC 143985901 — Ceftriaxone 250 mg injectionAI (15 hospitals, 255–399 samples)
• NDC 409733311 — Ceftriaxone 1 gram intravenous injectionAI (19 hospitals, 255–399 samples)
• NDC 00781-3400-78 — Ampicillin sodium injection, 125 mg/mL vialAI (65 hospitals, 66–399 samples)
• NDC 63323-0344-10 — Ceftriaxone injection 250 mgAI (46 hospitals, 255–399 samples)
• NDC 70594-0095-01 — Ceftriaxone 500 mg injectionAI (11 hospitals, 255–399 samples)
• NDC 70594-0095-02 — CEFTRIAXONE 500 MG SOLUTION FOR INJECTION (9 hospitals, 255–399 samples)
• NDC 43598-0914-25 — Vasopressin 20 units per mL intravenous solutionAI (173 hospitals, 137–398 samples)
• NDC 48582-0001-55 — Saliva stimulant combo spray bottleAI (403 hospitals, 263–398 samples)
• NDC 65628-0070-05 — Omeprazole oral suspensionAI (45 hospitals, 344–398 samples)
• NDC 00781-3119-64 — Enoxaparin injection 40 mg per 0.4 mLAI (17 hospitals, 182–398 samples)
• NDC 68462-0933-10 — Epinephrine 1 mg/mL injection ampuleAI (66 hospitals, 182–398 samples)
• NDC 71288-0432-91 — Enoxaparin 30 mg/0.3 mL prefilled syringeAI (75 hospitals, 65–398 samples)
• NDC 75907-0189-35 — Cyclophosphamide injection, 2 g per 10 mL IVAI (164 hospitals, 191–398 samples)
• NDC 66794-0213-42 — Ceftriaxone 1 gram injectionAI (17 hospitals, 379–397 samples)
• NDC 63323-0012-03 — Oxytocin injection, 10 units per mLAI (545 hospitals, 64–397 samples)
• NDC 49281-0589-05 — Meningococcal ACYW-135 vaccineAI (300 hospitals, 261–396 samples)
• NDC 70092-9221-38 — ROPIVACAINE 0.2% AMBIT KIT 400 ML KIT (6 hospitals, 288–396 samples)
• NDC 00264-5009-90 — Levetiracetam IV infusion in salineAI (69 hospitals, 126–396 samples)
• NDC 50474-0710-79 — Certolizumab pegol 400 mg syringe kitAI (633 hospitals, 215–395 samples)
• NDC 39822-5550-05 — Promethazine 50 mg/mL injectionAI (96 hospitals, 206–395 samples)
• NDC 74364203 — Leuprolide 7.5 mg syringe kitAI (171 hospitals, 296–395 samples)
• NDC 60505-6144-04 — Cefepime 1 gram powder for injectionAI (224 hospitals, 161–395 samples)
• NDC 5024206001 — BEVACIZUMAB 25 MG/ML INTRAVENOUS SOLUTIONAI (72 hospitals, 395 samples)
• NDC 00409-0528-25 — Levofloxacin 500 mg IV infusion in dextroseAI (57 hospitals, 53–395 samples)
• NDC 7126680065 — BEVACIZUMAB 1.25 MG/0.05ML IZ SOSY (1 hospital, 395 samples)
• NDC 7126680061 — BEVACIZUMAB 1.25 MG/0.05ML IZ SOSY (2 hospitals, 395 samples)
• NDC 9999999910 — BEVACIZUMAB 3.75 MG/0.15 ML OCULAR INJECTION (1 hospital, 395 samples)
• NDC 7144909144 — bevacizumab 25 mg/mL Soln 0.13 mL SYRINGE (3 hospitals, 395 samples)
• NDC 09999-8850-26 — alteplase 2 MG/2 ML Solution 2 mg Syringe (1 hospital, 224–395 samples)
• NDC 70436-0025-82 — Bivalirudin injection 250 mgAI (114 hospitals, 169–394 samples)
• NDC 409601025 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSIONAI (34 hospitals, 151–394 samples)
• NDC 80830-2365-01 — Propofol intravenous emulsion, 1000 mg per 100 mLAI (51 hospitals, 151–394 samples)
• NDC 67457-0813-50 — Daptomycin injection 500 mg IVAI (343 hospitals, 231–393 samples)
• NDC 70092-9588-38 — Ropivacaine 0.2% saline solution bagAI (60 hospitals, 348–393 samples)
• NDC 70004-0202-32 — Fentanyl citrate in saline IV solutionAI (46 hospitals, 150–393 samples)
• NDC 51754-6001-04 — Glycopyrrolate injectionAI (117 hospitals, 303–393 samples)
• NDC 61553-0416-40 — Morphine sulfate preservative-free injection, 10 mgAI (12 hospitals, 176–392 samples)
• NDC 58980-0409-25 — Glycerin rectal suppository (laxative)AI (305 hospitals, 239–392 samples)
• NDC 43066-0557-12 — Dexmedetomidine in saline solutionAI (154 hospitals, 68–392 samples)
• NDC 64208-2510-05 — Human albumin 5% intravenous solutionAI (101 hospitals, 49–391 samples)
• NDC 63323-0402-24 — Aztreonam 2 gram injectionAI (177 hospitals, 175–391 samples)
• NDC 70092-1133-04 — MORPHINE (PF) 1 MG/ML INJECTION SOLN WRAPPER [300512] (8 hospitals, 67–391 samples)
• NDC 70092-1380-03 — MORPHINE (PF) IN NS 1 MG/ML INTRAVENOUS SOLUTION [300126] (7 hospitals, 67–391 samples)